Amarin Corp Plc (AMRN)

[Mogwai]

Good point. I stated earlier I expect an ambiguous result. An example of the results I expect include something like this:

-Vascepa shows 7% decrease in events
-No statistical difference in death rate
-Time to first event is 5 months longer under the Vascepa arm

Now, what would a result like this do to the stock and Vascepa's future prospects?

I know a lot of people think this study is 100% clear cut, but I don't it that way. I think there will be a lot of gray area.